eMedonlineŽ is a health technology that can complement the therapeutic portfolio of pharmaceutical companies. It offers the potential to differentiate products in a competitive environment, and allows companies to collect compliance data in real time, correlate compliance with outcomes, and substantiate label claims. The system includes a hand-held device and web service that collect and distribute information between the patient and clinician. It enables direct data entry at the point of care and simultaneous transmission of that data to a central server with clinical interface. In this way, you can track drug use, map adherence to outcomes and dosing, and automatically collect data for predictive modeling.

eMedonline can provide the following advantages:

• Recover product revenues currently lost due to noncompliance
• Lower costs in clinical trials through more efficient data collection, better data, better adherence, easier audits
• Manage adverse events and maintain dose intensity in trials
• Greater speed to market with new drugs through more efficient trials
• Extend effective patient life
• Produce data-based label claims
• Protect position in formularies
• Facilitate FDA post-marketing commitment (PMC) Compliance
• Mitigate risk through collection of Phase IV surveillance data